A Case of Ceruminous Syringocystadenoma in the External Auditory Canal

Joon Taek Oh; Kyu Ha Shin; Eun Mee Han; Yun Suk An

doi:10.3342/kjorl-hns.2022.00353

Abstract

It is rare to find tumor of the ceruminous gland, which is a modified apocrine gland located within the skin of external auditory canal (EAC). Syringocystadenoma papilliferum (SCAP) is a benign adnexal tumor that occurs in the head and facial area in forms of infiltrative macules, papules, or keratinous nodules, but rarely in the EAC. To date, fewer than 150 case reports of SCAP have been reported, with SCAP in the EAC being extremely rare. We report a case of 51-year-old male with 2 year-history of a left EAC mass arising from the superior wall of the EAC. We performed a microscopic surgery, with the mass resected via retro-auricular approach under general anesthesia. The histopathological examination confirmed the specimen as SCAP. There were no complications or recurrence during the 4 months follow-up period.

Key words: Ceruminal adenoma ㆍ External auditory canal ㆍ Pathology ㆍ Syringocystadenoma

Introduction

Ceruminous glands are modified apocrine glands located within the skin of the external auditory canal (EAC). Tumors arising from the ceruminous glands are rare, accounting for only 5.7% of all external ear tumors [1]. According to the World Health Organization, ceruminous gland tumors can be classified into six categories according to its histological characteristics; 1) ceruminous adenoma, 2) ceruminous pleomorphic adenoma, 3) ceruminous syringocystadenoma papilliferum (SCAP), 4) ceruminous adenocarcinoma, 5) adenoid cystic carcinoma, and 6) mucoepidermoid carcinoma [2].

SCAP was first mentioned as a “naevus syringadenomatosus papilliferus” by dermatologists in the 20th century [3]. SCAP occurs in the head and facial area in forms of infiltrative macules, papules, or keratinous nodules and also rarely occurs in the EAC, with 50% being found after birth and 15%-30% during childhood [4].

Less than 150 cases of SCAP have been reported up to date and even fewer of those arising from the EAC. In this report, we describe the surgical removal of SCAP originating from the EAC via retro-auricular approach in an adult patient.

Case

A 51-year-old male patient visited our hospital presenting with a left EAC mass found incidentally 2 years ago. He complained of left ear fullness and hearing loss. Otoscopy revealed a mass arising from the superior wall of the left EAC, completely obstructing the auditory canal. The mass had a diameter of approximately 1.5 cm and was soft to touch, having a clear boundary with yellow discharge surrounding it (Fig. 1). The tympanic membrane could not be seen due to the mass. Mixed type hearing loss up to 51 dB with an air-bone gap of 41 dB was identified in pure tone audiometry (Fig. 2).

Enhanced temporal bone CT image confirmed an irregularly enhancing 1.7 cm sized round-shaped mass with clear margins located in the cartilaginous portion of the left EAC (Fig. 3A). Modification in the mastoid cortex due to the mass effect of the tumor was noted. Otherwise, there was no significant destruction of surrounding bony structures (Fig. 3B). Preoperative cranial nerve MRI with gadolinium enhancement showed a heterogeneous enhancing T1 low, T2 high lesion (Fig. 4).

The patient underwent microscopic surgery and the mass was resected via retro-auricular approach under general anesthesia. A 1.5×2×1 cm-sized elliptical mass with clear boundaries originating from the superior posterior portion of the EAC was confirmed and completely resected. The defect in the ear canal was reconstructed by elongation of the endomeatal skin followed by ear packing.

Histopathological examination confirmed the resected specimen as SCAP. The tumor showed dilated papillary and cystic structures (Fig. 5A) and was composed of luminal columnar epithelium with abundant eosinophilic cytoplasm and outer basal/myoepithelial cells (Fig. 5B).

The patient was discharged the day after the operation with no symptoms or complications. He visited the otorhinolaryngology outpatient clinic for regular follow ups and 4 months after the microscopic surgery, the resection site was well healed without any complications (Fig. 6).

This report was approved by the Institutional Review Board of the Bundang Jesaeng General Hospital (DMC 2022-03-008), and the requirement of informed consent was waived.

Discussion

SCAP is a benign adnexal tumor derived from the apocrine gland and is known to be associated with malignant tumors such as basal cell carcinoma, verrucous carcinoma, and tubular sweat gland carcinoma [5]. SCAP in the EAC may present with a range of symptoms depending on the degree of auricular canal blockage, from conductive hearing loss to aural fullness, otalgia, ear discharge and hemorrhage [6].

The characteristic pathological findings of SCAP are papillary hyperkeratotic epithelium with intradermal indentation. This papillary process connects directly with the tubular structure located deep in the indentation [7]. The process has a double layer within it, consisting of columnar epithelium abundant with eosinophilic cytoplasm and cuboidal epithelium with relatively scarce cytoplasm. Dense infiltration of plasma cells and lymphocytes are found in the interstitial space [8].

CT and MRI are important imaging modalities for the diagnosis of EAC tumors. While CT images show the location of the lesion and association with surrounding tissues, MRI images reveal the nature of the mass and help in differential diagnosis [8]. MRI of SCAP is reported to show intermediate signal intensity in both pre-contrast T1 and T2-weighted images, while showing weak enhancement in T1-weighted images with contrast. If the lesion shows low signal intensity in T2-weighted images or high enhancement after contrast, other types of tumors such as pleomorphic adenoma should be considered rather than SCAP [9].

Mammino and Vidmar [10] reported 144 cases of SCAP, of which 108 cases originated from the head and neck, 29 cases from the trunk, and 8 cases from the limbs. Since 11 cases of SCAP in the EAC reported by Müller and Theissig [11], 12 cases were reported up to date but the actual occurrence is considered to be more [12].

The low incidence and nonspecific symptoms of SCAP make the differential diagnosis of malignant neoplasms inevitable, also with the need for distinguishing benign ceruminous gland tumors, cholesteatoma, cholesteatomatous otitis media, and tuberculous otitis media [6]. In this case, we performed complete resection under general anesthesia as preoperative CT scans showed no evidence of infiltration into surrounding bone or tissue.

Complete tumor resection is the gold standard treatment for SCAP when there is no evidence of bony destruction in the surrounding EAC. Transcanal or retroauricular approach can be considered [6-8]. Although recurrence is rare following complete resection and current guidelines suggest no need for additional therapy, regular follow-up examination is recommended [6].

In conclusion we performed complete resection of the EAC tumor via retro-auricular approach under general anesthesia because preoperative CT scans showed no evidence of infiltration into the surrounding bone or tissue. SCAP was confirmed in histopathologic examination, and we report this case as SCAP in the EAC is an extremely rare case.

ACKNOWLEDGMENTS

None

Notes

Author Contribution

Conceptualization: Yun Suk An. Data curation: Joon Taek Oh, Kyu Ha Shin. Investigation: Joon Taek Oh. Project administration: Yun Suk An. Resources: Eun Mee Oh. Supervision: Yun Suk An, Kyu Ha Shin. Visualization: Joon Taek Oh, Eun Mee Han. Writing—original draft: Joon Taek Oh. Writing—review & editing: Yun Suk An, Kyu Ha Shin.

Fig. 1.

Endoscopic view of the left external auditory canal (EAC). The left EAC is totally obstructed by a protruding mass (asterisk) arising from its superior wall.

Fig. 2.

Pure tone audiometry report. The initial pure tone audiometry reveals 51 dB mixed type hearing loss in the left side with 41 dB air-bone gap.

Fig. 3.

Preoperative temporal bone CT scan of left EAC tumor. A: Enhanced axial CT scan shows a heterogeneously enhancing protruding mass (arrow) located in the outer portion of the left EAC. B: Enhanced coronal view of the tumor within the left EAC showing no evidence of invasion into surrounding bony structures. EAC, external auditory canal.

Fig. 4.

Preoperative cranial nerve MRI with gadolinium enhancement of the left EAC tumor. A: T1-weighted image demonstrating a heterogeneously enhancing low signal intensity lesion (arrow) in the left EAC. B: T2-weighted image of the left EAC tumor showing high signal intensity (arrow). EAC, external auditory canal.

Fig. 5.

Microscopic appearance of the tumor. A: Microscopic examination of tumor under H&E staining shows dilated papillary and cystic structures (H&E, ×100). B: The tumor is composed of luminal columnar epithelium with abundant eosinophilic cytoplasm and outer basal/myoepithelial cells (H&E, ×200). H&E, hematoxylin and eosin.

Fig. 6.

Follow up endoscopic examination 4 months after tumor resection. The resection site is well healed with no sign of disease or complications.

REFERENCES

1. Thompson LD, Nelson BL, Barnes EL. Ceruminous adenomas: A clinicopathologic study of 41 cases with a review of the literature. Am J Surg Pathol 2004;28(3):308-18.

2. Thompson LD. Update from the 4th edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the ear. Head Neck Pathol 2017;11(1):78-87.

3. Werther . Syringadenoma papilliferum (Naevus syringadenomatosus papilliferus). Archiv für Dermatologie und Syphilis 1913;116:865-70.

4. Karg E, Korom I, Varga E, Ban G, Turi S. Congenital syringocystadenoma papilliferum. Pediatr Dermatol 2008;25(1):132-3.

5. Helwig EB, Hackney VC. Syringadenoma papilliferum: Lesions with and without naevus sebaceous and basal cell carcinoma. AMA Arch Derm 1955;71(3):361-72.

6. Guerra-Jiménez G, González Aguado R, Arenas Rodríguez A, Ramos Macías Á. Syringocystadenoma papilliferum of the external auditory canal. Case report and literature review. Acta Otorrinolaringol Esp (Engl Ed) 2017;68(4):235-7.

7. Seo JY, Lee YJ, Choi HS, Lee MK. A case of tubular apocrine adenoma with syringocystadenoma papilliferum of external auditory canal removed by postauricular approach. Korean J Otorhinolaryngol-Head Neck Surg 2013;56(4):229-32.

8. A rechvo A, Balser is S, Neverausk iene L, A rechvo I. Syringocystadenoma papilliferum of the bony external auditory canal: A rare tumor in a rare location. Case Rep Otolaryngol 2013;2013:541679.

9. Kamakura T, Horii A, Mishiro Y, Takashima S, Kubo T. Magnetic resonance imaging of syringocystadenoma papilliferum of the external auditory canal. Auris Nasus Larynx 2006;33(1):53-6.

10. Mammino JJ, Vidmar DA. Syringocystadenoma papilliferum. Int J Dermatol 1991;30(11):763-6.

11. Müller R, Theissig F. [Syringocystadenoma papilliferum of the outer ear canal]. Laryngorhinootologie 1995;74(1):43-5.

12. Jang JH, Park SY, Park HY, Heo KW. A case of syringocystadenoma papilliferum of external auditory canal. Korean J Otorhinolaryngol-Head Neck Surg 2021;64(6):444-7.